Tumor escape and progression under immune pressure

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Manjili, Masoud H ^a   Egilmez, Nejat ^b   Knutson, Keith L ^c   Selvan, Senthamil R ^d   Ostberg, Julie R ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INDOLEAMINE 2,3 DIOXYGENASE; PROGRAMMED DEATH 1 RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER PROGNOSIS; CARCINOGENESIS; CELL EXPANSION; CELLULAR IMMUNITY; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; HODGKIN DISEASE; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CANCER; MALIGNANT MESOTHELIOMA; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; T LYMPHOCYTE; TUMOR ESCAPE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; NEOPLASM;

DISEASE PROGRESSION; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; NEOPLASMS; TUMOR ESCAPE;

EID: 84872140776     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/641079     Document Type: Editorial

References (0)